COMMUNIQUÉS West-GlobeNewswire

Heartflow Plaque Analysis Now Supported by Scientific Statements From American College of Cardiology and American Heart Association for Personalized Management of Patients with Suspected CAD
18/12/2025
Reinforces Role of AI-Powered Quantitative Coronary Plaque Assessment MOUNTAIN VIEW, Calif., Dec. 18, 2025 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the leader in AI technology for coronary artery [...]
Medline Announces Closing of Upsized Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
18/12/2025
NORTHFIELD, Ill., Dec. 18, 2025 (GLOBE NEWSWIRE) -- Medline Inc. (Nasdaq: MDLN) (“Medline”) announced today that it has closed its upsized initial public offering of 248,439,654 shares of its Class A common stock at a [...]
Resmed Announces Participation in the 44th Annual J.P. Morgan Healthcare Conference
18/12/2025
SAN DIEGO, Dec. 18, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, chairman and chief executive officer, and Dr. Carlos Nunez, chief medical officer, will present at the 44 th Annual [...]
Cartesian Therapeutics Announces the Appointment of Adrian Bot to Board of Directors
18/12/2025
FREDERICK, Md., Dec. 18, 2025 (GLOBE NEWSWIRE) -- Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (the “Company”), a clinical-stage biotechnology company pioneering cell therapy for autoimmune diseases, today announced the [...]
Abivax to be Added to Nasdaq Biotechnology Index
18/12/2025
Abivax to be Added to Nasdaq Biotechnology Index PARIS, France – December 18, 2025 – 10:05 pm CET – Abivax SA (Euronext Paris: FR0012333284 – ABVX / Nasdaq: ABVX) (“Abivax” or the “Company”), a clinical-stage [...]
Gain Therapeutics to Host Virtual KOL Event on GT-02287 for Parkinson’s Disease
18/12/2025
Event to be held January 6th, 2026, at 10 a.m. EST BETHESDA, Md., Dec. 18, 2025 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology company leading the [...]
Crinetics Pharmaceuticals to Participate in The 44th Annual J.P. Morgan Healthcare Conference
18/12/2025
SAN DIEGO, Dec. 18, 2025 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), today announced that that Scott Struthers, Ph.D., Founder and Chief Executive Officer of Crinetics, will present at the 44 th [...]
Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
18/12/2025
CONSHOHOCKEN, Pa., Dec. 18, 2025 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated [...]
vTv Therapeutics and M42’s IROS Announce Submission of Phase 2 Clinical Study Protocol for Cadisegliatin in Type 2 Diabetes to the United Arab Emirates Department of Health
18/12/2025
Trial to assess cadisegliatin as potential adjunctive therapy to insulin in patients with T2D HIGH POINT, N.C., Dec. 18, 2025 (GLOBE NEWSWIRE) -- vTv Therapeutics Inc. (Nasdaq: VTVT), a late-stage biopharmaceutical [...]
AVITA Medical to Present at the 44th Annual J.P. Morgan Healthcare Conference
18/12/2025
VALENCIA, Calif., Dec. 18, 2025 (GLOBE NEWSWIRE) -- AVITA Medical ® , Inc. (ASX: AVH, NASDAQ: RCEL), a leading therapeutic acute wound care company delivering transformative solutions, today announced that Cary Vance, [...]
Crescent Biopharma Announces Grants of Inducement Awards
18/12/2025
WALTHAM, Mass., Dec. 18, 2025 (GLOBE NEWSWIRE) -- Crescent Biopharma, Inc. (“Crescent” or the “Company”) (Nasdaq: CBIO), a biotechnology company dedicated to rapidly advancing the next wave of therapies for cancer [...]
Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
18/12/2025
FOSTER CITY, Calif., Dec. 18, 2025 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN), a commercial stage biopharmaceutical company, today reported that, effective December 17, 2025, it granted stock options to [...]
Annovis Announces Open-Label Extension Study for Parkinson's Disease Patients
18/12/2025
Enrollment will begin in January 2026 Participants will be treated with buntanetap for 36 months The study aims to enroll 500 patients MALVERN, Pa., Dec. 18, 2025 (GLOBE NEWSWIRE) -- Annovis Bio, Inc. (NYSE: ANVS) (“ [...]
Senti Biosciences Announces New Employment Inducement Grants
18/12/2025
SOUTH SAN FRANCISCO, Calif., Dec. 18, 2025 (GLOBE NEWSWIRE) -- Senti Biosciences, Inc. (Nasdaq: SNTI) (“Senti Bio”), a clinical-stage biotechnology company developing next-generation cell and gene therapies using its [...]
Nxera Pharma to Regain Full Rights to GPR52 Agonist Program for Schizophrenia
19/12/2025
Tokyo, Japan and Cambridge, UK, 19 December 2025 – Nxera Pharma Co. Ltd (“Nxera” or “the Company; TSE 4565) today announces that Boehringer Ingelheim has informed the Company of its decision not to exercise its [...]
CARBIOS maintient son objectif de construction de l’usine de Longlaville avec un calendrier ajusté
18/12/2025
CARBIOS réaffirme son ambition de poursuivre le projet de construction de l’usine à Longlaville en décalant le calendrier prévisionnel de trois mois. Le projet de construction de l’usine est aujourd’hui conforté par : [...]
CARBIOS maintains its commitment to build the Longlaville plant and adjusts its timeline
18/12/2025
CARBIOS reaffirms its ambition to pursue the Longlaville plant construction project and postpones the timeline by three-month. The plant construction project is supported by: Pre-commercialization contracts covering [...]
ENvue Medical, Formerly NanoVibronix, UroShield® Kit Secures Reimbursement in the UK
18/12/2025
Peak Medical, ENvue’s Exclusive Distributor in UK, Places Significant Order after Reimbursement Decision, Projecting Future Market Demand for UroShield® Kit TYLER, Texas, Dec. 18, 2025 (GLOBE NEWSWIRE) -- ENvue Medical [...]
AB Science annonce l’initiation de la couverture de son titre par Maxim Group avec un objectif de cours de 4,0 euros par action
18/12/2025
COMMUNIQUÉ DE PRESSE AB SCIENCE ANNONCE L’INITIATION DE LA COUVERTURE DE SON TITRE PAR MAXIM GROUP AVEC UN OBJECTIF DE COURS DE 4,0 EUROS PAR ACTION Paris, le 18 décembre 2025, 19h15 CET AB Science SA (Euronext - [...]

Pages